These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34453540)

  • 21. Pregnancy and neonatal complications in women with polycystic ovary syndrome in relation to second-trimester anti-Müllerian hormone levels.
    Valdimarsdottir R; Valgeirsdottir H; Wikström AK; Kallak TK; Elenis E; Axelsson O; Ubhayasekhera K; Bergquist J; Piltonen TT; Pigny P; Giacobini P; Poromaa IS
    Reprod Biomed Online; 2019 Jul; 39(1):141-148. PubMed ID: 31036431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia-A New Insight on Syndrome Pathogenesis.
    Ozegowska K; Korman M; Szmyt A; Pawelczyk L
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33322590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea.
    Carmina E; Fruzzetti F; Lobo RA
    Am J Obstet Gynecol; 2016 Jun; 214(6):714.e1-6. PubMed ID: 26767792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
    Bradbury RA; Lee P; Smith HC
    Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
    Yang S; Ruan J; Huang W; Tan J; Zhang X; Feng X; Liu D; Fu J; Zhou L; Zhou M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):819-24. PubMed ID: 26887768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic effect and safety of curcumin in women with PCOS: A systematic review and meta-analysis.
    Shen W; Qu Y; Jiang H; Wang H; Pan Y; Zhang Y; Wu X; Han Y; Zhang Y
    Front Endocrinol (Lausanne); 2022; 13():1051111. PubMed ID: 36387924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leptin Levels in Women With Polycystic Ovary Syndrome: A Systematic Review and a Meta-Analysis.
    Zheng SH; Du DF; Li XL
    Reprod Sci; 2017 May; 24(5):656-670. PubMed ID: 27798245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly elevated level of antimüllerian hormone associated with preterm delivery in polycystic ovary syndrome patients who underwent ovulation induction.
    Kaing A; Jaswa EA; Diamond MP; Legro RS; Cedars MI; Huddleston HG
    Fertil Steril; 2021 Feb; 115(2):438-446. PubMed ID: 32883514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome.
    Evliyaoglu O; Imöhl M; Weiskirchen R; van Helden J
    Clin Chem Lab Med; 2020 Jul; 58(8):1291-1301. PubMed ID: 32069226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of omega-3 polyunsaturated fatty acids on hormones, oxidative stress, and inflammatory parameters among polycystic ovary syndrome: a systematic review and meta-analysis.
    Yuan J; Wen X; Jia M
    Ann Palliat Med; 2021 Aug; 10(8):8991-9001. PubMed ID: 34488386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Metformin Treatment on Soluble Leptin Receptor Levels in Women with Polycystic Ovary Syndrome.
    Liu RB; Liu Y; Lv LQ; Xiao W; Gong C; Yue JX
    Curr Med Sci; 2019 Aug; 39(4):609-614. PubMed ID: 31346998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
    Feldman RA; O'Neill K; Butts SF; Dokras A
    Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulatory metastin/kisspeptin-1 in polycystic ovary syndrome: a systematic review and meta-analysis with diagnostic test accuracy.
    Varikasuvu SR; Prasad VS; Vamshika VC; Satyanarayana MV; Panga JR
    Reprod Biomed Online; 2019 Oct; 39(4):685-697. PubMed ID: 31515170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome.
    Le MT; Le VNS; Le DD; Nguyen VQH; Chen C; Cao NT
    Clin Endocrinol (Oxf); 2019 Apr; 90(4):579-585. PubMed ID: 30636332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Müllerian Hormone in Girls with Premature Adrenarche: The Impact of Polycystic Ovary Syndrome History in their Mothers.
    Efthymiadou A; Bogiatzidou M; Kritikou D; Chrysis D
    J Pediatr; 2019 Feb; 205():190-194. PubMed ID: 30529136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences of the association of anti-Müllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome.
    Woo HY; Kim KH; Rhee EJ; Park H; Lee MK
    Endocr J; 2012; 59(9):781-90. PubMed ID: 22673409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher luteinizing hormone levels associated with antimüllerian hormone in postmenarchal daughters of women with polycystic ovary syndrome.
    Crisosto N; Ladrón de Guevara A; Echiburú B; Maliqueo M; Cavada G; Codner E; Paez F; Sir-Petermann T
    Fertil Steril; 2019 Feb; 111(2):381-388. PubMed ID: 30527840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
    Piouka A; Farmakiotis D; Katsikis I; Macut D; Gerou S; Panidis D
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
    Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
    Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.